Mammalian target of rapamycin complex (mTORC) regulates a variety of cellular responses including proliferation, growth, differentiation and cell migration. In this study, we show that mammalian target of rapamycin complex 2 (mTORC2) regulates invasive cancer cell migration through selective activation of Akt1. Insulin-like growth factor-1 (IGF-1)-induced SKOV-3 cell migration was completely abolished by phosphatidylinositol 3-kinase (PI3K) (LY294002, 10 lM) or Akt inhibitors (SH-5, 50 lM), whereas inhibition of extracellular-regulated kinase by an ERK inhibitor (PD98059, 10 lM) or inhibition of mammalian target of rapamycin complex 1 (mTORC1) by an mTORC1 inhibitor (Rapamycin, 100 nM) did not affect IGF-1-induced SKOV-3 cell migration. Inactivation of mTORC2 by silencing Rapamycin-insensitive companion of mTOR (Rictor), abolished IGF-1-induced SKOV-3 cell migration as well as activation of Akt. However, inactivation of mTORC1 by silencing of Raptor had no effect. Silencing of Akt1 but not Akt2 attenuated IGF-1-induced SKOV-3 cell migration. Rictor was preferentially associated with Akt1 rather than Akt2, and overexpression of Rictor facilitated IGF-1-induced Akt1 activation. Expression of PIP3-dependent Rac exchanger1 (P-Rex1), a Rac guanosine exchange factor and a component of the mTOR complex, strongly stimulated activation of Akt1. Furthermore, knockdown of P-Rex1 attenuated Akt activation as well as IGF-1-induced SKOV-3 cell migration. Silencing of Akt1 or P-Rex1 abolished IGF-1-induced SKOV-3 cell invasion. Finally, silencing of Akt1 blocked in vivo metastasis, whereas silencing of Akt2 did not. Given these results, we suggest that selective activation of Akt1 through mTORC2 and P-Rex1 regulates cancer cell migration, invasion and metastasis.
Mammalian target of rapamycin complex (mTORC) regulates a variety of cellular responses including proliferation, growth, differentiation and cell migration. In this study, we show that mammalian target of rapamycin complex 2 (mTORC2) regulates invasive cancer cell migration through selective activation of Akt1. Insulin-like growth factor-1 (IGF-1)-induced SKOV-3 cell migration was completely abolished by phosphatidylinositol 3-kinase (PI3K) (LY294002, 10 lM) or Akt inhibitors (SH-5, 50 lM), whereas inhibition of extracellular-regulated kinase by an ERK inhibitor (PD98059, 10 lM) or inhibition of mammalian target of rapamycin complex 1 (mTORC1) by an mTORC1 inhibitor (Rapamycin, 100 nM) did not affect IGF-1-induced SKOV-3 cell migration. Inactivation of mTORC2 by silencing Rapamycin-insensitive companion of mTOR (Rictor), abolished IGF-1-induced SKOV-3 cell migration as well as activation of Akt. However, inactivation of mTORC1 by silencing of Raptor had no effect. Silencing of Akt1 but not Akt2 attenuated IGF-1-induced SKOV-3 cell migration. Rictor was preferentially associated with Akt1 rather than Akt2, and overexpression of Rictor facilitated IGF-1-induced Akt1 activation. Expression of PIP3-dependent Rac exchanger1 (P-Rex1), a Rac guanosine exchange factor and a component of the mTOR complex, strongly stimulated activation of Akt1. Furthermore, knockdown of P-Rex1 attenuated Akt activation as well as IGF-1-induced SKOV-3 cell migration. Silencing of Akt1 or P-Rex1 abolished IGF-1-induced SKOV-3 cell invasion. Finally, silencing of Akt1 blocked in vivo metastasis, whereas silencing of Akt2 did not. Given these results, we suggest that selective activation of Akt1 through mTORC2 and
Introduction
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase, and forms two distinct molecular complexes, mTORC1 and mTORC2. mTOR binds Raptor and mLST8, and forms rapamycin-sensitive molecular complex mTORC1 (Kim et al., 2002) . mTORC1 is thought to be activated by nutrition and controls autonomous growth of cells by regulating S6K1 and 4E-BP1. Therefore, rapamycin has been used for anti-cancer treatment. However, some clinical trials (O'Reilly et al., 2006) showed that rapamycin increases Akt activation in certain malignancies, indicating that there are negative feedback loops through which mTORC1 inhibits Akt activation. Indeed, S6K directly phosphorylates insulin receptor substrate on Ser270 and promotes insulin resistance (Zhang et al., 2008) . It also has been reported that mTORC1-dependent activation of S6K negatively regulates phosphatidylinositol 3-kinase (PI3K) signaling pathways (Zhang et al., 2007; Carracedo et al., 2008) . A link between mTOR and Akt has been strengthened by the identification of another mTOR complex, rapamycin-insensitive companion of mTOR (Rictor). mTOR interacts with the Rictor protein independently of Raptor and mLST8 (mTORC2) (Jacinto et al., 2004; Sarbassov et al., 2004) . mTORC2 is rapamycin-insensitive and thought to regulate proliferation, survival and rearrangement of the actin cytoskeleton. Although mTORC1-dependent regulation of growth has been studied extensively, the role of mTORC2 in cellular physiology is relatively unknown. However, a recent finding that mTORC2 directly phosphorylates Akt on Ser473 provides hints for mTORC2 functions relative to the roles of Akt in cancer (Sarbassov et al., 2005) .
Akt is a serine/threonine kinase that is activated in a PI3K-dependent manner (Datta et al., 1999) . Elevation of cellular phosphatidylinositol-3, 4, 5-trisphosphate by PI3K ultimately leads to the activation of Akt by phosphorylation at Thr308 and Ser473 residues (Alessi and Cohen, 1998) . Activation of Akt is achieved by structural changes induced by phosphatidylinositol 3-phosphate-dependent kinase-1 (PDK-1)-dependent phosphorylation at Thr308, and stabilization is induced by mTORC2-dependent phosphorylation at Ser473 (Sarbassov et al., 2005) . In mammals, the Akt family of enzymes consists of three isoforms (Akt1, Akt2 and Akt3) that are encoded by three separate genes, and share more than 80% homology in amino acid sequence (Brazil et al., 2004) . Although Akt isoforms share high sequence homology, distinctive functions of each Akt isoform have been reported. For example, recent studies using knock-out mice models or cell lines have provided evidence for isoform-specific functions of Akt. Mice lacking Akt1 show small organism size throughout their life span (Cho et al., 2001b) . On the other hand, mice lacking Akt2 show a type 2 diabetes-like syndrome (Cho et al., 2001a) . Additional studies have demonstrated isoform-specific functions of Akt as follows: Akt2 is required for insulin-induced glucose uptake (Bae et al., 2003) and is required for cell cycle progression and cell migration (Kim et al., 2008a; Yun et al., 2009) . However, it is still not clear whether Akt isoforms are differentially activated by upstream signaling pathways or have distinctive downstream substrates.
Migration is a key process for cancer cell invasion and metastasis. Inhibition of PI3K activity virtually blocks migration induced by G protein-coupled receptors or by receptor tyrosine kinase, suggesting that PI3K has a critical role in cell migration (reviewed in (Barber and Welch, 2006) ). Akt isoforms have key regulatory roles in mediating cell migration through effects downstream of PI3K. It has been reported that the Akt1 isoform mediates cell migration induced by lysophosphatidic acid or by platelet-derived growth factor (Kim et al., 2008a, b) . However, Akt2 is not essential for lysophosphatidic acid-or platelet-derived growth factor-induced migration of cells. In particular, Akt1 is selectively activated and localized to membrane-ruffling regions, indicating that during cell migration upstream signaling is relayed to selective activation of Akt1 rather than Akt2.
Circulating level of insulin-like growth factor-1 (IGF-1) has been shown to be associated with development of various cancers and metastasis (Dunn et al., 1998; Wu et al., 2002; van Golen et al., 2006) . In this study, we provide evidence that IGF-1-dependent activation of Akt1, but not Akt2, is mediated by molecular interaction with mTORC2. Preferential activation of Akt1 regulates cancer cell migration, invasion and metastasis. Additionally, our data suggest that the phosphatidylinositol-3, 4, 5-trisphosphate-dependent Rac exchanger1 (P-Rex1) has a pivotal role in mTORC2/Akt1 signaling pathways, leading to migration of cancer cells.
Results
The Akt1 isoform has an essential role in IGF-induced SKOV-3 cell migration The insulin-like growth factor (IGF) system has a central role in disease pathogenesis including tumorigenesis (LeRoith et al., 1995) as well as in many functions of normal tissues. To define the molecular mechanism underlying IGF-1-induced cancer cell migration and invasion, we examined the effect of on SKOV-3 ovarian cancer cell migration of signaling interventions. We used pharmacological inhibitors or the silencing of specific genes. IGF-1 (50 ng/ml) significantly stimulated SKOV-3 cell migration in a time-dependent manner ( Figure 1a) . Stimulation of SKOV-3 cells with IGF-1 for 10 min resulted in the activation of Akt, ERK and S6K (Figure 1b) . Pharmacological inhibition of PI3K (LY294002, 10 mM) and Akt (SH-5, 50 mM) completely blocked IGF-1-dependent activation of Akt and S6K (Figure 1b) , as well as IGF-1-induced SKOV-3 cell migration (Figure 1c) . In contrast, inhibition of ERK1/2 (PD98059, 10 mM) and mTORC1-dependent activation of S6K by Rapamycin (100 nM) (Figure 1b) did not affect IGF-1-induced SKOV-3 cell migration ( Figure 1c ). As IGF-1-induced SKOV-3 cell migration was blocked by the inhibition of Akt, we examined the role of Akt isoforms in SKOV-3 cell migration. Silencing of Akt1 did not affect the expression of Akt2 or vise versa (Figure 1d ). Silencing Akt1 significantly attenuated IGF-1-induced phosphorylation of total Akt, whereas silencing Akt2 had no effect (Figures 1e and f) . Consistent with this finding, IGF-1-induced SKOV-3 cell migration was only affected by the silencing of Akt1, not Akt2 (Figure 1g ). mTORC2-dependent activation of Akt is essential for SKOV-3 cell migration As mTOR has pivotal roles in the activation of Akt and actin cytoskeleton rearrangements (Sarbassov et al., 2004 (Sarbassov et al., , 2005 , we verified the role of each mTOR complex in the activation of Akt and migration. Silencing of mTOR in SKOV-3 cells resulted in a defect in IGF-1-induced activation of Akt and migration (Figures 2a and  b) . However, disruption of mTORC1 by the silencing of Raptor had no effect on the activation of Akt and SKOV-3 cell migration. Unlike the effect of mTORC1 inactivation, disruption of mTORC2 by silencing of Rictor significantly blunted IGF-1-induced activation of Akt, as well as SKOV-3 cell migration (Figures 2a and b) . mTORC2 selectively activates Akt1 rather than Akt2 As IGF-1-induced SKOV-3 cell migration was dependent on mTORC2 and an Akt1 isoform, we verified signaling specificity linking mTORC2 and Akt1. To determine which complex of mTOR activates Akt1, we first defined the molecular interaction of Akt1 with mTOR complexes. Raptor, a component of mTORC1, was not co-immunoprecipitated with Akt1, whereas Rictor, a component of mTORC2, was strongly associated with Akt1 ( Figure 3a and Supplementary Figure S1a ). IGF-1 did not alter the interaction between Rictor and Akt1. Because IGF-1-induced SKOV-3 migration was preferentially mediated by Akt1 rather than Akt2 (Figure 1f ), we next examined whether mTORC2 preferentially forms a molecular complex with Akt1. We found that Rictor was preferentially associated with Akt1 but not with Akt2 ( Figure 3b ). Consistent with this, IGF-1 preferentially activated Akt1 rather than Akt2. Furthermore, expression of Rictor preferentially enhanced IGF-1-induced activation of Akt1 (Figures 3c and d ).
P-Rex1 forms molecular complex with Akt1 and enhances IGF-1-induced activation mTOR-dependent activation of Rac small G protein is mediated by P-Rex1 (Hernandez-Negrete et al., 2007) . To determine the effect of P-Rex1 on the activation of Akt1, we examined the interaction of P-Rex1 with the mTOR complex. P-Rex1 was associated with Raptor or Rictor equally, regardless of IGF-1 stimulation ( Figure 4a ). As Akt1 was preferentially associated with the mTORC2 complex (Figure 3b ), and P-Rex1 was equally associated with the mTOR complex (Figure 4a ), we examined whether immunoprecipitation of Akt1 selectively co-immunoprecipitated P-Rex1. As shown in Figure 4b , a higher amount of P-Rex1 was coimmunoprecipitated with Akt1 than Akt2. In addition, over-expression of P-Rex1 selectively enhanced the phosphorylation of Akt1. However, phosphorylation of Akt2 was unaffected by the expression of P-Rex1 ( Figure 4c and Supplementary Figure S1b PI3K inhibitor; LY294002, 10 mM), SH-5 (an Akt inhibitor, 50 mM), PD (an extracellular-regulated kinase inhibitor; PD98059, 10 mM) or Rapa (an mammalian target of rapamycin complex 1 inhibitor; Rapamycin, 100 nM), followed by stimulation with IGF-1 (50 ng/ml) for 10 min. Cell lysates were analyzed by western blotting using the indicated antibodies. (c) SKOV-3 cell migration was examined in the same context as described in Figure 1b . (d) Lysates from vector, shAkt1 or shAkt2 expressing cells were analyzed by western blotting using the indicated antibodies. (e, f) IGF-1-dependent activation of Akt was verified by western blotting in cells silencing Akt1 or Akt2, and phosphorylation of Akt was quantified as described in 'Materials and methods' section. (g) SKOV-3 cell migration was determined after silencing Akt1 or Akt2. *Po0.05, **P40.05. Figure 2 Disruption of mammalian target of rapamycin complex 2 attenuates insulin-like growth factor-1-induced activation of Akt and migration. (a) Activation of Akt was examined by western blotting using phospho-Akt (Ser473) antibody. Silencing of mTOR, Raptor and Rictor was verified by western blotting using specific antibodies against the indicated proteins. (b) SKOV-3 cell migration was determined after silencing mTOR, Raptor or Rictor. *Po0.05, **P40.05. cells silencing P-Rex1 (Figure 5d ). To delineate the signaling sequence between Akt1 and P-Rex1, we examined SKOV-3 cell migration after expression of CA-Akt1 in cells silencing P-Rex1 ( Figure 5e ). As shown in Figure 5f , expression of CA-Akt1 resulted in the elevation of basal migration. However, CA-Akt1-induced migration of SKOV-3 cells was blunted by the silencing of P-Rex1. To verify the necessity of Akt1 during mTORC2-dependent cell migration, we next assessed the effect of CA-Akt1 on the migration of SKOV-3 cells silencing Rictor ( Figure 5g ). As shown in Figure 5h , expression of CA-Akt1 rescued impairment of migration in SKOV-3 cells silencing Rictor. In addition to cell migration, CA-Akt1 also rescued defects of invasiveness in SKOV-3 cells silencing Rictor (Supplementary Figure S2) . P-Rex1 and Akt1 are required for membrane-ruffling formation as well as for Rac1 activation Rac small G proteins have critical roles in migration in a variety of cell types (Chung et al., 2000) . As activation of Rac1 leads to membrane ruffling, we examined Rac1 translocation as well as membrane ruffling in cells silencing Akt1 or Akt2. Stimulation of control and Akt2 silencing SKOV-3 cells with IGF-1 induced membrane-ruffling formation and caused Rac1 to be translocated to the ruffling region. However, cells silencing Akt1 did not show membrane ruffling or Rac translocation (Figure 6a ). Membrane ruffling and Rac translocation were not observed in cells silencing Rictor or P-Rex1, whereas silencing of Raptor had no effect (Figure 6b ). In addition, activation of Rac was abolished in cells silencing Akt1 and P-Rex1, whereas silencing of Akt2 did not affect Rac activation (Figures 6c, d and e). To verify the role of Akt1 on P-Rex1-mediated Rac1 activation, we assessed the effect of Akt1 expression on the P-Rex1 interaction with Rictor. As shown in Supplementary Figure S3a , expression of Akt1 did not affect the interaction of P-Rex1 with Rictor. However, translocation of P-Rex1 to the membrane-ruffling region was not observed in cells silencing Akt1 but not Akt2 (Supplementary Figures S3b and c) . were co-transfected with Myc-tagged PIP3-dependent Rac exchanger1 (P-Rex1) and either HA-tagged Raptor or Rictor, and stimulated with insulin-like growth factor-1 (IGF-1) (50 ng/ml) for 10 min. Cell lysates were immunoprecipitated with anti-Myc antibody, and pellets were immunoblotted with anti-Raptor and anti-Rictor antibodies, respectively. (b) HEK293 cells were cotransfected with HA-tagged P-Rex1 and either FLAG-tagged Akt1 or Akt2. Cell lysates were immunoprecipitated with anti-FLAG antibody, and association of P-Rex1 was verified by western blotting using anti-HA antibody. (c, d) FLAG-tagged Akt1 or Akt2 was cotransfected with Myc-tagged P-Rex1, and HEK 293 cells were stimulated with IGF-1 (50 ng/ml) for 10 min. Activation of Akt was verified by western blotting with anti-phospho-Akt (S473) antibody and quantified as described in 'Materials and methods' section. *Po0.05, **P40.05. Figure 3 Rictor is selectively associated with Akt1 and enhances its phosphorylation at Ser473. (a) HEK293 cells were cotransfected with FLAG-tagged Akt1 and either HA-tagged Raptor or Rictor, and stimulated with insulin-like growth factor-1 (IGF-1) (50 ng/ml) for 10 min. Cell lysates were immunoprecipitated with anti-FLAG antibody and pellets were immunoblotted with either anti-HA or anti-FLAG antibodies. (b) HEK293 cells were cotransfected with HA-tagged Rictor and either FLAG-tagged Akt1 or Akt2. Cell lysates were immunoprecipitated with anti-FLAG antibody, and association of Rictor was verified by western blotting using anti-HA antibody. (c, d) FLAG-tagged Akt1 or Akt2 was cotransfected with HA-tagged Rictor, and HEK 293 cells were stimulated with IGF-1 (50 ng/ml) for 10 min. Activation of Akt was verified by western blotting with anti-phospho-Akt (S473) antibody, and quantified as described in 'Materials and methods' section. *Po0.05, **P40.05.
P-Rex1 and Akt1 are required for invasion and in vivo metastasis As Akt1 and P-Rex1 regulate SKOV-3 cell migration, we next examined the effects of Akt1 and P-Rex1 silencing on matrigel invasion. Silencing of Akt1 diminished IGF-1-induced SKOV-3 cell invasion, whereas silencing of Akt2 did not (Figure 7a ). Silencing of P-Rex1 also blunted IGF-1-induced SKOV-3 cell invasion (Figure 7b ). To confirm whether Akt1-dependent invasiveness is related to metastasis, we used A549 lung cancer cells, which are highly metastatic cells. The migration and invasion of A549 cells were also blocked by the silencing of either Akt1 or PRex1. However, silencing of Akt2 had no effect (Supplementary Figure S4) . A549 cells silencing either Akt1 or Akt2 expressed green fluorescence protein using pMIGR2 bicistronic retroviral vector for optical imaging. Tail vein injection of Vector or Akt2 silencing A549 cells significantly increased the size of lung (Figure 7c) , and histological analysis revealed that almost all the cells are replaced with metastasized A549 lung cancer cells (Figure 7d ). However, injection of A549 cells silencing Akt1 did not increase lung mass (Figure 7c ) and showed few metastasized A549 colonies, as judged by histological analysis (Figure 7d ). In addition, optical-imaging experiments demonstrated that green fluorescence was highly detected in lungs that are isolated from mice injected with A549 cells silencing Akt2 but not Akt1 (Figure 7e ).
Discussion
In this study, we examined mechanism that mediates the ability of Akt isoforms to differentially affect cancer cell migration, invasion and metastasis. PI3K generates locomotor activity of cells by production of phosphatidylinositol 3, 4, 5-trisphosphate. It has been reported that PI3K has a crucial role in the activation of mTOR kinase (Kim et al., 2002; Jacinto et al., 2004; Sarbassov et al., 2004 Sarbassov et al., , 2005 . mTOR exists as two multi-subunit complexes and mediates many physiological responses such as growth, proliferation, survival and migration. mTORC1, which is PI3K-dependent and the rapamycin sensitive complex, have essential roles in human cancer development through promoting cell growth by direct phosphorylation of translational regulators, such as ribosomal S6 kinase1 (S6K1) and 4E-BP1. Activation of mTORC2 is PI3K-dependent but rapamycin insensitive. There is still a debate on the signaling specificity of each mTOR complex during cancer cell migration. Nonetheless, it appears that mTORC2 is a major downstream effector of PI3K in mediating cancer cell migration: mTORC2 regulates actin cytoskeleton rearrangement (Jacinto et al., 2004; Sarbassov et al., 2004) ; inhibition of mTORC1 by rapamycin did not affect cell migration ( Figure 1c) ; disruption of mTORC2 by silencing the Rictor gene blunted cell migration, whereas silencing of Raptor had no effect (Figure 2b) . Therefore, mTORC2-mediated signaling pathways might be important for cancer cell migration. 
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Although mTORC2 appears to be involved in the regulation of the actin cytoskeleton and possibly in cancer cell migration, the downstream mediators of mTORC2 have not been fully elucidated. Recently, it was reported that Akt is phosphorylated by mTORC2 at Ser473 residue (Sarbassov et al., 2005) . Consistent with this, our results also showed that disruption of mTORC2 by the silencing of Rictor resulted in the impairment of Akt activation (Figure 2a) . However, inhibition of mTORC1 by rapamycin or disruption of mTORC1 by silencing Raptor did not affect Akt activation (Figures 1b and 2a) . It is notable that cancer cell migration was only affected by impairment of mTORC2/Akt signaling pathways (Figures 1c and 2b) . Indeed, Akt controls invasive migration through the regulation of multiple processes that are involved in actin organization, cell-to-cell adhesion, cell motility and extracellular matrix degradation (Kim et al., 2001; Grille et al., 2003; Enomoto et al., 2005) . Fine analysis using genetically engineered models has demonstrated that ablation of Akt retards tumorigenesis and cancer cell migration (Ju et al., 2007) . In addition, mouse embryonic fibroblast cells lacking Akt1 impeded cell migration, whereas cells lacking Akt2 showed normal migration compared with wild-type cells (Zhou et al., 2006; Kim et al., 2008a, b) . In line with this, our results demonstrated that silencing of Akt1 but not Akt2 blunted cancer cell migration, invasion and metastasis (Figures 1g, 7a and c-e) . Therefore, it is likely that invasive cell migration is specifically mediated by the Akt1 isoform. However, the underlying mechanism by which the Akt1 isoform exerts its effects on cell migration is still unclear.
One important issue that arises from our study is the isoform specificity of Akt during growth factor-induced cell migration. One plausible explanation is that formation of different molecular complexes leads to the different functions of Akt isoforms. Recently, it has been reported that Akt interacts with the mTOR complex (Jacinto et al., 2004) . As silencing of Rictor abolished Akt phosphorylation, it is possible that Akt1 is preferentially associated with mTORC2. Indeed, our results showed that Akt1 is preferentially associated with Rictor, whereas its association with Raptor was negligible (Figure 3a) . In addition, Rictor was selectively associated with Akt1 rather than Akt2 (Figure 3b ). The isoform-specific interaction of Akt with mTORC2 appears to generate its activation, as forced expression of Rictor selectively induced Akt1 but not Akt2 phosphorylation (Figures 3c and d) . In this regard, growth factor-induced mTORC2 signaling would be selectively transduced to the Akt1 isoform, and leads to specific activation of Akt1. Consistent with this idea, the overall phosphorylation of Akt was reduced in the absence of Akt1, whereas silencing of Akt2 had no effect (Figures 1e  and f) . It is also notable that Akt1 was basally associated with mTORC2, and growth factor stimulation did not further evoke the association of Akt1 with mTORC2. Hence, it is reasonable that Akt1 might stably associate with mTORC2 even after activation by mTORC2. Given these results, it is likely that Akt1 rather than Akt2 spontaneously associates with mTORC2, and that growth factor stimulation preferentially activates the Akt1 isoform, thereby regulating invasive migration. Recently, it was suggested that the linker region of Akt1 makes it able to translocate to membrane ruffles during fibroblast cell migration (Kim et al., 2008a) . However, it is still unclear which domain is responsible for the association of Akt1 with mTORC2.
Activation of Rac small G proteins has an essential role in growth factor-mediated membrane-ruffling formation and migration. In this study, we showed that silencing of Akt1 blunts Rac1 activation and membrane ruffling (Figures 6a and c) . However, the mechanism underlying Rac activation is not known. Recently, it was reported that P-Rex1, a Rac guanine nucleotide exchange factor, stably interacts with the mTOR complex (Hernandez-Negrete et al., 2007) . Likewise, our results showed that P-Rex1 interacts with both Raptor and Rictor (Figure 4a ), regulates Rac1 activation, and membrane-ruffling formation (Figures 6b, d , and e). It is likely that Akt1 has essential roles in P-Rex1-mediated Rac1 activation and migration. For example, silencing of Akt1 leaded to impediment of Rac1 translocation and activation (Figures 6a and c) . In addition, silencing of Akt1 blunted IGF-1-induced P-Rex1 translocation to membrane-ruffling region (Supplementary Figure S3c) . In line with this, the constitutively active form of Akt1 could not rescue migration in cells silencing P-Rex1 (Figures 5e and f) , indicating that P-Rex1 is downstream of Akt1 in mediating cell migration. Although Akt1 seems to be necessary for proper activity of P-Rex1, activation of Akt1 is likely to require P-Rex1-dependent Rac1 activation. For example, forced expression of P-Rex1 resulted in the augmentation of Akt1 activation ( Figures  4c and d) , and silencing of P-Rex1 blocked growth factor-induced activation of Akt (Figures 5b and c) . In line with this, it has been reported that the constitutively active form of Rac1, which is a downstream mediator of P-Rex1 signaling, activates Akt (Higuchi et al., 2001) . Therefore, it is reasonable that there exists a positive feedback loop in between Akt1 and P-Rex1/Rac1 during growth factor-induced cell migration. Cancer cells are metastasized by a so-called invasion that is regulated by complex mechanisms that are involved in epithelial-mesenchymal transitions, matrix degradation, cell-to-cell or cell-to-matrix interactions and basic motility (Sheng et al., 2009) . Collagen gel invasion was dramatically abrogated by silencing of Akt1 or P-Rex1. However, the knockdown of Akt2 had no effect (Figures 7a and b) , indicating that selective activation of the Akt1/P-Rex1 loop regulates cancer cell invasion. The effect of Akt1 on metastasis was further demonstrated using A549 lung cancer cells, in which invasion was specifically blunted by silencing P-Rex1 or Akt1 but not Akt2 (Supplementary Figure S4) . Consistent with the results from invasion assays, in vivo metastasis was significantly blocked by knockdown of Akt1 but not Akt2 (Figures 7c-e) . Therefore, selective activation of Akt1 might contribute to cancer cell metastasis.
In conclusion, this study shows that Akt isoforms have distinct functions in cancer cell migration, invasion and metastasis. It also provides mechanistic insight into selective activation of Akt1 by mTORC2 and positive feedback loops in between Akt1 and P-Rex1/Rac1 pathways. Although it is still unclear how Akt1 regulates the locomotor activity of cancer cells, further studies regarding isoform-specific function of Akt1 on cancer cell metastasis should provide more efficient strategies for Akt-targeted cancer therapies.
Materials and methods

Reagents and antibodies
Dulbecco's modified Eagle's medium, fetal bovine serum, trypsin-ethylenediaminetetraacetic acid, and antibiotics were purchased from Hyclone Laboratories Inc. (Logan, UT, USA). Anti-pan-Akt, anti-Akt1, anti-Akt2, anti-phospho-Akt (Ser473), anti-p70S6K1, anti-phospho-p70S6K1 (Thr389), anti-ERK1/2, anti-phospho-ERK1/2 (Thr202/Tyr204), anti-mTOR, anti-Raptor and anti-Rictor were obtained from Cell Signaling Technology (Boston, MA, USA). Anti-Rac1 and anti-HA epitope antibodies were purchased from Upstate Biotechnology (Lake Placid, NY, USA). Rapamycin, anti-FLAG and anti-FLAG M2-agarose were purchased from Sigma-Aldrich (St Louis, MO, USA). Rhodamine-phalloidin, 4 0 ,6-diamidino-2-phenylindole (DAPI) and Alexa Fluor 488-conjugated goat anti-mouse secondary antibody were purchased from Molecular Probes, Inc. (Carlsbad, CA, USA). LY294002, PD98059 and SH-5 inhibitors were purchased from Calbiochem (Darmstadt, Germany). IRDye700-and IRDye800-conjugated rabbit/mouse secondary antibodies were obtained from Li-COR Bioscience (Lincoln, NE, USA). Recombinant human IGF-1 and all other reagents were high quality and were purchased from Sigma-Aldrich (St Louis, MO, USA), unless otherwise indicated.
Plasmid construction FLAG-tagged murine Akt1 and Akt2 were introduced into a retroviral vector, pMIGR2, as described previously (Kim et al., 2008a) . The constitutively active Akt1 construct (S308D/ S473D) was a gift from Dr Daniel L Altschuler (University of Pittsburgh, Pittsburgh, PA, USA). FLAG-tagged murine constitutively expressing Akt1 was sub-cloned into a pMIGR2 retroviral vector via EcoRI/BamHI sites. Myc-or HA-tagged Raptor and Rictor constructs were a gift from Dr Do Hyung Kim (University of Minnesota, MN, USA). Myc-or HAtagged P-Rex1 plasmids were obtained from Dr Mikio Hoshino (Kyoto University, Kawaguchi, Japan). All the constructs were fully sequenced to ensure that no other mutation was inadvertently introduced.
Cell culture and transfection A549 and HEK293FT cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum and penicillin/streptomycin, and maintained at 37 1C in 5% CO 2 . SKOV-3 cells were cultured in Roswell Park Memorial Institute (RPMI) medium. For transient expression, HEK293FT cells were transfected with various plasmids by the calcium phosphate method. Cell-free culture supernatant and cells were harvested for viral infection and co-immunoprecipitation assay, respectively.
Co-immunoprecipitation and western blotting
For co-immunoprecipitation assays, cells were lysed with essentially the same buffer, as described previously (Kim et al., 2002) . Briefly, cleared cell extracts were mixed with 2 mg of FLAG M2-agarose and incubated for 2 h. Immunoprecipitates were washed with lysis buffer three times and mixed with sample buffer. Samples were subjected to 8-15% gradient polyacrylamide gel electrophoresis and transferred onto a nitrocellulose membrane. Membranes were incubated with the indicated primary antibodies and IRDye-conjugated secondary antibodies, and protein bands were visualized using an Infrared image analyzer (Li-COR Bioscience).
Analysis of mRNA expression
The expression of P-Rex1 mRNA was quantified by reverse transcription PCR (RT-PCR) analysis after isolation of total RNA using TRIZOL reagents, as described in the manufacturer's protocol (Invitrogen, Carlsbad, CA, USA). One microgram of total RNA was reverse transcribed into cDNA using ImProm-II reverse transcription systems (Promega Biotec, Madison, WI, USA), which was then amplified by PCR using specific primers for P-Rex1 (forward, 5 0 -catccagcaatacgtggaagatgg-3 0 ; reverse, 5 0 -aggagaaggtgacattgtccagct-3 0 ), GAPDH (forward, 5 0 -gagtc aacggatttggtcgt-3 0 ; reverse, 5 0 -tgtggtcatgagtccttcca-3 0 ). Equal amounts of RT-PCR products were separated on a 2% agarose gel and stained with ethidium bromide.
Migration and invasion assays
The migration of SKOV-3 cells was measured as described previously (Kim et al., 2008a) . For invasion assays, SKOV-3 cells were serum starved for 12 h (1 Â 10 5 ) and overlaid on top of a 24-well Trans-well plate (Corning Coastar Corp., Cambridge, MA, USA), in which artificial basement membrane had been produced by 50 mg of Matrigel (BD Bioscience, San Jose, CA, USA). Invasion was induced by placing the cells on overlaid inserts of serum-free medium either in the absence or presence of IGF-1 for 24 h. The insert was fixed with 4% paraformaldehyde, and non-migratory cells on the top-side of the membrane were removed by gently wiping with a cotton swab. The membrane was stained with DAPI, and invasive cells were counted under the fluorescence microscope at Â 10 magnification (Axiovert200, Carl Zeiss, Jena, Germany).
Retroviral gene expression
Generation of retroviral particles for the expression of genes and their infection were performed essentially, as described previously (Bae et al., 2003) . Infected cells were sorted at the same fluorescence intensity using a FACSAria cell sorter (BD Bioscience).
Lentiviral gene silencing
For generation of lentiviruses expressing shRNA, pLKO.1 constructs (2 mg) were co-transfected with pVSV-G (0.2 mg) and D8.9 (2 mg) by the calcium phosphate method in HEK293FT cells. Viral particles were harvested at 24 and 48 h, and infected into cells in the presence of 8 mg/ml of polybrene. Infected cells were selected with puromycin (10 mg/ ml). Target sequences were 5 0 -cgagtttgagtacctgaagct-3 0 (sh-Akt1), 5 0 -cgacccaacacctttgtcata-3 0 (sh-Akt2), 5 0 -aaccctgcc tttgtcatgcct-3 0 (sh-mTOR), 5 0 -caccaccaaagcaacctatag-3 0 (shrictor), 5 0 -cacctcactttatttccatgt-3 0 (sh-Raptor), and 5 0 -ggacc atgctggaggacatct-3 0 (sh-P-Rex1).
Immunocytochemistry SKOV-3 cells were grown in 6-well plates on coverslips, were serum starved for 12 h, and then stimulated with IGF-1 (50 ng/ ml). Cells were fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, and incubated with anti-Rac1 and Rhodamine-phalloidin for 1 h, followed by incubation with Alexa Fluor 488-conjugated secondary antibody for 30 min. Images were obtained with a confocal microscope at Â 40 magnification (OLYMPUS FV-1000, Tokyo, Japan) and enlarged 3X in silico.
Rac1 activation assay
The level of active GTP-bound Rac1 was determined by pulling-down GTP-bound Rac1 with GST-PAK-RBD coupled to glutathione agarose beads. Cells were stimulated with IGF-1 for 5 min, and lysed with lysis buffer containing 50 mM Tris, pH 7.5, 1% Nonidet P-40, 150 mM NaCl, 5 mM MgCl 2 , 10% glycerol, 1 mg/ml leupeptin, 1 mg/ml aprotinin and 1 mM phenylmethylsulfonyl fluoride. Lysates were centrifuged, and supernatants were incubated with beads coupled to GST-PAK-RBD for 2 h at 4 1C. Beads were washed with lysis buffer and bound GTP-loaded Rac1 was eluted with sample buffer. The amount of active Rac1 was determined by western blot analysis.
Analysis of metastasis A549 lung cancer cells were caused to express green fluorescence protein to discriminate injected cells from surrounding cells or tissues. After silencing either Akt1 or Akt2, A549 cells (5 Â 10 6 ) were injected into the lateral tail vein of nude mice. Animals were sacrificed 9 weeks after injection and lung tissues were isolated. Spectral fluorescence images were obtained using the MAESTRO in-vivo Imaging System (CRi Inc., Woburn, MA, USA). Lung sections were stained with H&E and visualized with MIRAX MIDI Versatile Digital Slide Scanner (Carl Zeiss, Jena, Germany).
Statistical analysis
For analysis of migration and invasion, results are expressed as the mean ± s.d. of two independent experiments (n ¼ 3 for each experiment). For analysis of western blotting, results are expressed as the mean±s.d. of three independent experiments. When comparing two groups, an unpaired Student's t-test was used to assess differences. P-values less than 0.05 were considered significant and indicated as *, and P-values higher than 0.05 were considered insignificant and indicated as **.
